Amit Agrawal

Amit Agrawal serves as the Chief Scientific Officer for the Diagnostics Platform at Danaher Corporation and holds a position as a Member of the Board at InveniAI. Previously, Amit held multiple senior leadership roles at Novartis, including Global Head of Data42, SVP of Precision Medicine, and SVP of Portfolio Strategy and Management in Global Drug Development. Amit's prior experience also includes serving as Chief Operating Officer at Bellerophon Therapeutics and as Head of Corporate Strategy at Amgen, where roles included Executive Director of Digital Innovation and Director of Strategy and Corporate Development. Amit earned a Ph.D. in Biomedical Engineering from the Georgia Institute of Technology and a Graduate Certificate in Entrepreneurship and Venture Capital from the Georgia Tech Scheller College of Business.